Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian B Godman

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pharmacoeconomics - Open|February 15, 2018
Evaluating the Treatment Costs for Uncomplicated Malaria at a Public Healthcare Facility in Nigeria and the ImplicationsCharles C Ezenduka, Daniel Resende Falleiros, Brian B Godman
International Journal of Clinical Practice|January 17, 2017
An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia's public sector: Findings and therapeutic implicationsDan Kibuule, Mwangana Mubita, Ester Naikaku, et al.
BMJ (Clinical Research Ed.)|December 21, 2010
Getting better value from the NHS drug budgetJames C Moon, Andrew S Flett, Brian B Godman, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 23, 2022
Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisionsDaniel Resende Faleiros, Everton Nunes da Silva, Andreia C Santos, et al.
Basic & Clinical Pharmacology & Toxicology|February 18, 2014
An analytical framework for assessing drug and therapeutics committee structure and work processes in tertiary Brazilian hospitalsElisangela da Costa Lima-Dellamora, Rosângela Caetano, Lars L Gustafsson, et al.
Hospital Practice (1995)|July 31, 2018
Prevalence of chronic kidney disease using estimated glomerular filtration rate among diabetes patients attending a tertiary clinic in BotswanaGodfrey Mutashambara Rwegerera, Onkabetse Julia Molefe-Baikai, Anthony Masaka, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 1, 2016
Budget impact analysis of medicines: updated systematic review and implicationsDaniel Resende Faleiros, Juliana Álvares, Alessandra Maciel Almeida, et al.
Antibiotics (Basel, Switzerland)|June 28, 2023
Antimicrobial Dispensing Practices during COVID-19 and the Implications for PakistanBushra Gul, Maria Sana, Aneela Saleem, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 11, 2021
Budget impact analysis of medicines: estimated values versus real-world evidence and the implicationsDaniel Resende Faleiros, Juliana Alvares-Teodoro, Everton Nunes da Silva, et al.
Frontiers in Pharmacology|May 30, 2013
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugsRickard E Malmström, Brian B Godman, Eduard Diogene, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pharmacoeconomics - Open|February 15, 2018
Evaluating the Treatment Costs for Uncomplicated Malaria at a Public Healthcare Facility in Nigeria and the ImplicationsCharles C Ezenduka, Daniel Resende Falleiros, Brian B Godman
International Journal of Clinical Practice|January 17, 2017
An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia's public sector: Findings and therapeutic implicationsDan Kibuule, Mwangana Mubita, Ester Naikaku, et al.
BMJ (Clinical Research Ed.)|December 21, 2010
Getting better value from the NHS drug budgetJames C Moon, Andrew S Flett, Brian B Godman, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 23, 2022
Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisionsDaniel Resende Faleiros, Everton Nunes da Silva, Andreia C Santos, et al.
Basic & Clinical Pharmacology & Toxicology|February 18, 2014
An analytical framework for assessing drug and therapeutics committee structure and work processes in tertiary Brazilian hospitalsElisangela da Costa Lima-Dellamora, Rosângela Caetano, Lars L Gustafsson, et al.
Hospital Practice (1995)|July 31, 2018
Prevalence of chronic kidney disease using estimated glomerular filtration rate among diabetes patients attending a tertiary clinic in BotswanaGodfrey Mutashambara Rwegerera, Onkabetse Julia Molefe-Baikai, Anthony Masaka, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 1, 2016
Budget impact analysis of medicines: updated systematic review and implicationsDaniel Resende Faleiros, Juliana Álvares, Alessandra Maciel Almeida, et al.
Antibiotics (Basel, Switzerland)|June 28, 2023
Antimicrobial Dispensing Practices during COVID-19 and the Implications for PakistanBushra Gul, Maria Sana, Aneela Saleem, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 11, 2021
Budget impact analysis of medicines: estimated values versus real-world evidence and the implicationsDaniel Resende Faleiros, Juliana Alvares-Teodoro, Everton Nunes da Silva, et al.
Frontiers in Pharmacology|May 30, 2013
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugsRickard E Malmström, Brian B Godman, Eduard Diogene, et al.
Pageof 1